ARCHIMEDLIFE

Our goal is to make biomarkers accessible for patients. Physicians and their patients shall benefit from additional supportive biomarkers for better diagnosis and/or disease monitoring. ARCHIMEDlife´s Dual Strategy is to develop biomarker tests that can be used for diagnostic purposes. Beneficial biomarker tests shall not stay on a research level. Our Development Division (ISO 13485 certified) has all requirements and expertise to validate and certify biomarker tests to make them accessible for patients in a daily routine laboratory... Our diagnostic services help to improve diagnosis, chance for treatment and to help families, including their children, obtain a fast and reliable diagnosis... We, at ARCHIMEDlife Research Institute, put significant effort into the discovery and testing of novel biomarkers.

Registration numbers: 388448y (W)

Primary location: Vienna Austria